Oxford Immunotec Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 192

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $441M

Oxford Immunotec General Information

Description

Developer of T Cell-based diagnostic test products and services designed to focus on developing and commercializing proprietary tests for underserved immune-regulated conditions. The company focuses on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions and its research and development activities focus on Chronic infections, Transplantation, Autoimmune and Inflammatory disease, Immune oncology.

Contact Information

Formerly Known As
Anbajoti
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 143 Park Drive
  • Milton Park
  • Abingdon OX14 4SE
  • England, United Kingdom
Primary Industry
Diagnostic Equipment
Acquirer
Vertical(s)
Corporate Office
  • 143 Park Drive
  • Milton Park
  • Abingdon OX14 4SE
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oxford Immunotec Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Merger/Acquisition 08-Mar-2021 $441M Completed Generating Revenue
13. Secondary Transaction - Open Market 16-Apr-2018 Completed Generating Revenue
12. Secondary Transaction - Open Market 13-Apr-2017 Completed Generating Revenue
11. Secondary Transaction - Open Market 21-Mar-2014 Completed Generating Revenue
10. IPO 22-Nov-2013 Completed Generating Revenue
9. Later Stage VC 04-Jan-2013 Completed Generating Revenue
8. Later Stage VC 18-Jun-2012 Completed Generating Revenue
7. Later Stage VC (Series D) 30-Apr-2010 Completed Generating Revenue
6. Later Stage VC (Series C) 29-Oct-2007 $40M $57.2M Completed Generating Revenue
5. Secondary Transaction - Private 01-Mar-2006 $17.2M Completed Startup
To view Oxford Immunotec’s complete valuation and funding history, request access »

Oxford Immunotec Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of T Cell-based diagnostic test products and services designed to focus on developing and commercializing prop
Diagnostic Equipment
Abingdon, United Kingdom
192 As of 2021

Waltham, MA
 

Lausanne, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Oxford Immunotec Competitors (6)

One of Oxford Immunotec’s 6 competitors is Revvity, a Corporation company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Revvity Corporation Waltham, MA
Abionic Venture Capital-Backed Lausanne, Switzerland
Abbott Corporation Abbot Park, IL
Bio-Rad Laboratories Corporation Hercules, CA
BioChain Institute Private Equity-Backed Newark, CA
To view Oxford Immunotec’s complete competitors history, request access »

Oxford Immunotec Patents

Oxford Immunotec Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202105479-D0 Liquid waste collector and apparatus for performing an automated assay process Inactive 16-Apr-2021
GB-202105478-D0 Sieve plate and apparatus for performing an automated elispot process Inactive 16-Apr-2021
WO-2022219312-A2 Sieve plate and apparatus for performing an automated elispot process Inactive 16-Apr-2021
WO-2022219312-A3 Sieve plate and apparatus for performing an automated elispot process Inactive 16-Apr-2021
GB-202105476-D0 Target entity isolation in an assay process Inactive 16-Apr-2021
To view Oxford Immunotec’s complete patent history, request access »

Oxford Immunotec Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oxford Immunotec Former Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
AlbionVC Venture Capital Minority
Apollo Global Management PE/Buyout Minority
Dow Venture Capital Corporate Venture Capital Minority
HR Ventures Corporate Venture Capital Minority
Invesco Asset Management Asset Manager Minority
You’re viewing 5 of 19 investors. Get the full list »

Oxford Immunotec Acquisitions (3)

Oxford Immunotec’s most recent deal was a Merger/Acquisition with Immunetics for . The deal was made on 12-Oct-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Immunetics 12-Oct-2016 Merger/Acquisition Biotechnology
Imugen 01-Jul-2016 Merger/Acquisition Laboratory Services (Healthcare)
Boulder Diagnostics 31-Jul-2014 Merger/Acquisition Biotechnology
To view Oxford Immunotec’s complete acquisitions history, request access »

Oxford Immunotec ESG

Risk Overview

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Laboratory Equipment and Services

Subindustry

Rank

Percentile

To view Oxford Immunotec’s complete esg history, request access »

Oxford Immunotec FAQs

  • When was Oxford Immunotec founded?

    Oxford Immunotec was founded in 2002.

  • Where is Oxford Immunotec headquartered?

    Oxford Immunotec is headquartered in Abingdon, United Kingdom.

  • What is the size of Oxford Immunotec?

    Oxford Immunotec has 192 total employees.

  • What industry is Oxford Immunotec in?

    Oxford Immunotec’s primary industry is Diagnostic Equipment.

  • Is Oxford Immunotec a private or public company?

    Oxford Immunotec is a Private company.

  • What is the current valuation of Oxford Immunotec?

    The current valuation of Oxford Immunotec is .

  • What is Oxford Immunotec’s current revenue?

    The current revenue for Oxford Immunotec is .

  • How much funding has Oxford Immunotec raised over time?

    Oxford Immunotec has raised $187M.

  • Who are Oxford Immunotec’s investors?

    AlbionVC, Apollo Global Management, Dow Venture Capital, HR Ventures, and Invesco Asset Management are 5 of 19 investors who have invested in Oxford Immunotec.

  • Who are Oxford Immunotec’s competitors?

    Revvity, Abionic, Abbott, Bio-Rad Laboratories, and BioChain Institute are some of the 6 competitors of Oxford Immunotec.

  • When was Oxford Immunotec acquired?

    Oxford Immunotec was acquired on 08-Mar-2021.

  • Who acquired Oxford Immunotec?

    Oxford Immunotec was acquired by Revvity.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process